Science & Medicine Group Expands as Commercial Data Insights Leader with Amplion Acquisition
Science and Medicine Group Inc.(SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in life sciences and healthcare, announced that it has acquired the assets of Amplion Inc., an innovator in AI-powered data intelligence for life science marketing and sales teams seeking to identify business opportunities and accelerate sales growth.
Amplion's machine learning-based capabilities enable commercial teams to precisely target the right accounts and most appropriate, and often hard-to-reach, decision makers in pharma, biotech and academia. The Amplion platform and intuitive browser-based user interface provides new levels of hyper-personalized targeting, prospecting, scalability, speed and automation to improve sales and marketing far beyond conventional methods and existing manually searched contact databases.
The Amplion knowledgebase analyzes more than 35 million data sources in real-time to generate detailed insights using AI and machine learning on 8 million+ individual contacts across approximately 21,000 organizations globally.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
